Trial intelligence / Profile preview

Weekly versus tri-weekly cisplatin-based chemoradiation in locally advanced cervical cancer

KCT0003214Phase 3Recruiting

Sponsor
Korean Gynecologic Oncology Group
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cisplatin in Cervical Cancer (CC), sponsored by Korean Gynecologic Oncology Group. Started Apr 2012; status: recruiting.

02

Drugs

cisplatin
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on KCT0003214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call